Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 1/20 | 1.00 |
| ▸ | CES2 | O00748 | 2/20 | 0.62 |
| ▸ | CES1 | P23141 | 2/20 | 0.62 |
| ▸ | SRC | P12931 | 2/20 | 0.59 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.59 |
| ▸ | HPGD | P15428 | 1/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | PKM | P14618 | 1/20 | 0.48 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.48 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.48 |
| ▸ | BLM | P54132 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.44 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Mandelic Acid SCHEMBL5313046 | 1.00 | LMNA (1.00) | LMNAMAPK1CES2CES1SRC | |
| Mandelic Acid SCHEMBL21647917 | 1.00 | LMNA (1.00) | LMNAMAPK1CES2CES1SRC | |
| Mandelic Acid SCHEMBL1050 | 1.00 | LMNA (1.00) | LMNAMAPK1CES2CES1SRC | |
| Mandelic Acid SCHEMBL29777368 | 1.00 | LMNA (1.00) | LMNAMAPK1CES2CES1SRC | |
| Mandelic Acid SCHEMBL255601 | 1.00 | LMNA (1.00) | LMNAMAPK1CES2CES1SRC | |
| Mandelic Acid SCHEMBL1374278 | 0.97 | LMNA (0.95) | LMNAMAPK1CES2CES1SRC | |
| Mandelic Acid SCHEMBL3934174 | 0.97 | LMNA (0.95) | LMNAMAPK1CES2CES1SRC | |
| Mandelic Acid SCHEMBL9188111 | 0.97 | LMNA (0.95) | LMNAMAPK1CES2CES1SRC | |
| Mandelic Acid SCHEMBL1680817 | 0.97 | LMNA (0.95) | LMNAMAPK1CES2CES1SRC | |
| Mandelic Acid SCHEMBL5000945 | 0.97 | LMNA (0.95) | LMNAMAPK1CES2CES1SRC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2994 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12630520-B2 | Left-handed bicyclic morpholine and salt thereof, preparation method therefor, pharmaceutical composition, and use | INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2026-05-19 | — | — | US | claimed |
| WO-2026086809-A1 | PROCESS FOR PREPARING 3- [ (3AS, 6AR) -5- {5-CHLORO-2- [ (1-METHYL-1H-PYRAZOL-4-YL) AMINO] PYRIMIDIN-4-YL} -3A-METHYL-OCTAHYDROPYRROLO [3, 4-C] PYRROLE-2-YL] -3-OXOPROPIONITRILE | BEIJING INNOCARE PHARMA TECH CO., LTD. (CN) | 2026-04-30 | — | — | WO | claimed |
| EP-4688761-A1 | (S)-TIANEPTINE AND USE IN TREATING DISORDERS AND CONDITIONS ASSOCIATED WITH PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR | Tonix Pharma Limited (IE) | 2026-02-11 | — | — | EP | claimed |
| EP-4661890-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | Purdue Research Foundation (US) | 2025-12-17 | — | — | EP | claimed |
| EP-3908582-B1 | SOLID FORMS COMPRISING (S)-4-(4-(4-(((2-(2,6-DIOXOPIPERIDIN-3-YL)-1-OXOISOINDOLIN-4-YL)OXY)METHYL) BENZYL)PIPERAZIN-1-YL)-3-FLUOROBENZONITRILE AND SALTS THEREOF, AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME | CELGENE CORP (US) | 2025-11-12 | — | — | EP | claimed |
| EP-4626904-A1 | MANDELIC ACID SALT OF PALMITOYL LYSYLVALYL-LYSINE | DSM IP Assets B.V. (NL) | 2025-10-08 | — | — | EP | claimed |
| US-20250276974-A1 | PROCESS FOR PREPARING ZANUBRUTINIB IN AMORPHOUS FORM | OLON S.P.A. (IT) | 2025-09-04 | — | — | US | claimed |
| US-20250270361-A1 | CHIRAL METAL OXIDE NANOSTRUCTURE, AND METHOD FOR PRODUCING SAME | EWHA UNIVERSITY-INDUSTRY COLLABORATION FOUNDATION (KR) | 2025-08-28 | — | — | US | claimed |
| CN-115820483-B | Gluconobacter oxydans capable of tolerating high-concentration mandelic acid and application thereof | 江南大学 | 2025-06-24 | — | — | CN | claimed |
| CN-120192277-A | Preparation method of etomidate | 仁合益康集团有限公司 | 2025-06-24 | — | — | CN | claimed |
| CN-1803756-A | Process for the preparation of cyclopropyl carboxylic acid esters and derivativesr | ASTRAZENECA AB (SE) | 2006-07-19 | — | — | CN | claimed |
| CN-1740156-A | Diastereomeric salts of terfenadine | MERRELL PHARMA INC (US) | 2006-03-01 | — | — | CN | claimed |
| CN-1431992-A | Process for preparation of cyclopropyl carboxylic acid esters and derivatives thereof | ASTRAZENECA AB (SE) | 2003-07-23 | — | — | CN | claimed |
| US-20030120105-A1 | Process for the preparation of cyclopropyl carboxylic acid esters and derivatives | ASTRAZENECA AB (SE) | 2003-06-26 | — | — | US | claimed |
| EP-1015432-B1 | SEPARATION OF ENANTIOMERS OF OCTAHYDROISOQUINOLINE | B I CHEMICALS INC (US) | 2002-05-02 | — | — | EP | claimed |
| CN-1309121-A | Method for resolving alpha- [ 4- (1, 1-dimethylethyl) phenyl ] -4- (hydroxydiphenylmethyl) -1-piperidinebutanol and compounds derived therefrom | MERRELL DOW PHARMA (US) | 2001-08-22 | — | — | CN | claimed |
| US-5663354-A | Process for preparing enantiomerically pure 6-[(4-chlorophenyl) (1H-1,2,4-triazol-1-yl) methyl]-1-methyl-1H-benzotrizole | JANSSEN PHARMACEUTICA, N.V. (BE) | 1997-09-02 | — | — | US | claimed |
| CN-1148382-A | Process and diastereomeric salts for optical resolution of racemic alpha- [4- (1, 1-dimethylethyl) phenyl ] -4- (hydroxydiphenylmethyl) -1-piperidinebutanol and compounds derived therefrom | MERRELL DOW PHARMA (US) | 1997-04-23 | — | — | CN | claimed |
| EP-0668861-A1 | PROCESS FOR PREPARING ENANTIOMERICALLY PURE 6- (4-CHLOROPHENYL)(1H --TRIAZOL-1,2,4-TRIAZOL-1-YL)METHYL]-1-METHYL-1H --BENZOTRIAZOLE | JANSSEN PHARMACEUTICA N.V. (BE) | 1995-08-30 | — | — | EP | claimed |
| WO-1994011364-A1 | PROCESS FOR PREPARING ENANTIOMERICALLY PURE 6-[(4-CHLOROPHENYL)(1H^_-TRIAZOL-1,2,4-TRIAZOL-1-YL)METHYL]-1-METHYL-1H^_-BENZOTRIAZOLE | JANSSEN PHARMACEUTICA N.V. (BE) | 1994-05-26 | — | — | WO | claimed |